The Inflation Reduction Act (IRA), a sweeping federal law enacted in August 2022, included many provisions aimed at making prescription drugs more affordable under Medicare Part D, the Medicare program that provides prescription drug coverage.
Two major changes to Medicare Part D went into effect in January 2024 and will significantly impact certain Medicare enrollees.
Read on for a discussion of how these provisions work, including how they could impact a person living with HIV or other high-cost condition, as well as related policy issues that will play out over the next year and beyond as the IRA’s changes begin to take effect.
Read the latest edition of Health Care in Motion.
Press Release, Health Law & Policy, Commentary
2025 State of Hep C Medicaid Access Report Cards Show Policy Gains and Ongoing Challenges Amid Shifting Federal Landscape
January 21, 2026